Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FABRY'S DISEASE: CLASSIFICATION AS A SPHINGOLIPIDOSIS AND PARTIAL CHARACTERIZATION OF A NOVEL GLYCOLIPID.

Authors: Sang H Shin; Stefanie Kluepfel-Stahl; Adele M Cooney; Christine R Kaneski; Jane M Quirk; Raphael Schiffmann; Roscoe O Brady; Gary J Murray
Journal: Pharmacogenet Genomics Date: 2008-09 Impact factor: 2.089

Review 5. Gene therapy for Fabry disease.

Authors: C Siatskas; J A Medin
Journal: J Inherit Metab Dis Date: 2001 Impact factor: 4.982

Review 6. Progress in investigations of sphingolipidoses.

Authors: M Adachi; L Schneck; B W Volk
Journal: Acta Neuropathol Date: 1978-08-07 Impact factor: 17.088

Review 7. Enzyme replacement therapy and beyond-in memoriam Roscoe O. Brady, M.D. (1923-2016).

Authors: Markus Ries
Journal: J Inherit Metab Dis Date: 2017-03-17 Impact factor: 4.982

8. Angiokeratoma corporis diffusum (Anderson-Fabry disease) in a single large family in Nova Scotia.

Authors: M W Spence; J T Clarke; D M D'Entremont; G A Sapp; E R Smith; A L Goldbloom; G Davar
Journal: J Med Genet Date: 1978-12 Impact factor: 6.318

9. [Lipoid chemical studies on angiokeratoma corporis diffusum (Fabry's syndrome)].

Authors: K H Vogelberg; H G Solbach; F A Gries
Journal: Klin Wochenschr Date: 1969-09-01

10. Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect.

Authors: James L Park; Steven E Whitesall; Louis G D'Alecy; Liming Shu; James A Shayman
Journal: Clin Exp Pharmacol Physiol Date: 2008-06-18 Impact factor: 2.557